메뉴 건너뛰기




Volumn 13, Issue 11, 2017, Pages 662-675

Fatigue as a symptom or comorbidity of neurological diseases

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMANTADINE; BETA INTERFERON; BETA1A INTERFERON; CYTOKINE; DOPAMINE RECEPTOR STIMULATING AGENT; GLATIRAMER; LEVACECARNINE; MODAFINIL; NATALIZUMAB; TERIFLUNOMIDE; VITAMIN D; HORMONE;

EID: 85032454390     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2017.117     Document Type: Review
Times cited : (280)

References (179)
  • 3
    • 84963018413 scopus 로고
    • A practical treatise on nervous exhaustion, (neurasthenia); Its symptoms
    • W Wood & Company
    • Beard, G. M. A Practical Treatise on Nervous Exhaustion, (Neurasthenia); Its Symptoms, Nature, Sequences, Treatment. (W. Wood & Company, 1880).
    • (1880) Nature, Sequences, Treatment
    • Beard, G.M.1
  • 5
    • 1542297793 scopus 로고    scopus 로고
    • The assessment of fatigue: A practical guide for clinicians and researchers
    • Dittner, A. J., Wessely, S. C. & Brown, R. G. The assessment of fatigue: A practical guide for clinicians and researchers. J. Psychosom. Res. 56, 157-170 (2004).
    • (2004) J. Psychosom. Res. , vol.56 , pp. 157-170
    • Dittner, A.J.1    Wessely, S.C.2    Brown, R.G.3
  • 6
    • 1642333956 scopus 로고    scopus 로고
    • Fatigue in neurological disorders
    • Chaudhuri, A. & Behan, P. O. Fatigue in neurological disorders. Lancet 363, 978-988 (2004).
    • (2004) Lancet , vol.363 , pp. 978-988
    • Chaudhuri, A.1    Behan, P.O.2
  • 7
    • 84873623522 scopus 로고    scopus 로고
    • Fatigue and fatigability in neurologic illnesses: Proposal for a unified taxonomy
    • Kluger, B. M., Krupp, L. B. & Enoka, R. M. Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy. Neurology 80, 409-416 (2013).
    • (2013) Neurology , vol.80 , pp. 409-416
    • Kluger, B.M.1    Krupp, L.B.2    Enoka, R.M.3
  • 8
    • 0242288106 scopus 로고    scopus 로고
    • Levodopa improves physical fatigue in Parkinson's disease: A double-blind, placebo-controlled, crossover study
    • Lou, J. S. et al. Levodopa improves physical fatigue in Parkinson's disease: A double-blind, placebo-controlled, crossover study. Mov. Disord. 18, 1108-1114 (2003).
    • (2003) Mov. Disord. , vol.18 , pp. 1108-1114
    • Lou, J.S.1
  • 9
    • 33846523586 scopus 로고    scopus 로고
    • The relationship between subjective fatigue and cognitive fatigue in advanced multiple sclerosis
    • Bailey, A., Channon, S. & Beaumont, J. G. The relationship between subjective fatigue and cognitive fatigue in advanced multiple sclerosis. Mult. Scler. 13, 73-80 (2007).
    • (2007) Mult. Scler. , vol.13 , pp. 73-80
    • Bailey, A.1    Channon, S.2    Beaumont, J.G.3
  • 10
    • 0034633712 scopus 로고    scopus 로고
    • Fatigue and declines in cognitive functioning in multiple sclerosis
    • Krupp, L. B. & Elkins, L. E. Fatigue and declines in cognitive functioning in multiple sclerosis. Neurology 55, 934-939 (2000).
    • (2000) Neurology , vol.55 , pp. 934-939
    • Krupp, L.B.1    Elkins, L.E.2
  • 11
    • 0030873086 scopus 로고    scopus 로고
    • Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: A 18F-fluorodeoxyglucose positron emission tomography study
    • Roelcke, U. et al. Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: A 18F-fluorodeoxyglucose positron emission tomography study. Neurology 48, 1566-1571 (1997).
    • (1997) Neurology , vol.48 , pp. 1566-1571
    • Roelcke, U.1
  • 12
    • 0036339422 scopus 로고    scopus 로고
    • Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis
    • Filippi, M. et al. Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis. Neuroimage 15, 559-567 (2002).
    • (2002) Neuroimage , vol.15 , pp. 559-567
    • Filippi, M.1
  • 13
    • 29644442602 scopus 로고    scopus 로고
    • Fatigue in multiple sclerosis: An example of cytokine mediated sickness behaviour
    • Heesen, C. et al. Fatigue in multiple sclerosis: An example of cytokine mediated sickness behaviour J. Neurol. Neurosurg. Psychiatry 77, 34-39 (2006).
    • (2006) J. Neurol. Neurosurg. Psychiatry , vol.77 , pp. 34-39
    • Heesen, C.1
  • 14
    • 13444302611 scopus 로고    scopus 로고
    • Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis
    • Gottschalk, M. et al. Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis. Arch. Neurol. 62, 277-280 (2005).
    • (2005) Arch. Neurol. , vol.62 , pp. 277-280
    • Gottschalk, M.1
  • 15
    • 33746564555 scopus 로고    scopus 로고
    • Fatigue in progressive multiple sclerosis is associated with low levels of dehydroepiandrosterone
    • Téllez, N. et al. Fatigue in progressive multiple sclerosis is associated with low levels of dehydroepiandrosterone. Mult. Scler. 12, 487-494 (2006).
    • (2006) Mult. Scler. , vol.12 , pp. 487-494
    • Téllez, N.1
  • 16
    • 84887621358 scopus 로고    scopus 로고
    • Treatment of sleep disorders may improve fatigue in multiple sclerosis
    • Veauthier, C. et al. Treatment of sleep disorders may improve fatigue in multiple sclerosis. Clin. Neurol. Neurosurg. 115, 1826-1830 (2013).
    • (2013) Clin. Neurol. Neurosurg. , vol.115 , pp. 1826-1830
    • Veauthier, C.1
  • 17
    • 80053402234 scopus 로고    scopus 로고
    • Fatigue in multiple sclerosis is closely related to sleep disorders: A polysomnographic cross-sectional study
    • Veauthier, C. et al. Fatigue in multiple sclerosis is closely related to sleep disorders: A polysomnographic cross-sectional study. Mult. Scler. 17, 613-622 (2011).
    • (2011) Mult. Scler. , vol.17 , pp. 613-622
    • Veauthier, C.1
  • 18
    • 33746493300 scopus 로고    scopus 로고
    • Sleep and fatigue in multiple sclerosis
    • Stanton, B. R., Barnes, F. & Silber, E. Sleep and fatigue in multiple sclerosis. Mult. Scler. 12, 481-486 (2006).
    • (2006) Mult. Scler. , vol.12 , pp. 481-486
    • Stanton, B.R.1    Barnes, F.2    Silber, E.3
  • 19
    • 0023795328 scopus 로고
    • Chronic fatigue in primary care prevalence, patient characteristics, and outcome
    • Kroenke, K., Wood, D. R., Mangelsdorff, A. D., Meier, N. J. & Powell, J. B. Chronic fatigue in primary care. prevalence, patient characteristics, and outcome. JAMA 260, 929-934 (1988).
    • (1988) JAMA , vol.260 , pp. 929-934
    • Kroenke, K.1    Wood, D.R.2    Mangelsdorff, A.D.3    Meier, N.J.4    Powell, J.B.5
  • 20
    • 0141523110 scopus 로고    scopus 로고
    • Chronic fatigue and sociodemographic characteristics as predictors of psychiatric disorders in a community-based sample
    • Taylor, R. R., Jason, L. A. & Jahn, S. C. Chronic fatigue and sociodemographic characteristics as predictors of psychiatric disorders in a community-based sample. Psychosom. Med. 65, 896-901 (2003).
    • (2003) Psychosom. Med. , vol.65 , pp. 896-901
    • Taylor, R.R.1    Jason, L.A.2    Jahn, S.C.3
  • 21
    • 44449151576 scopus 로고    scopus 로고
    • The relationship between prior psychiatric disorder and chronic fatigue: Evidence from a national birth cohort study
    • Harvey, S. B., Wadsworth, M., Wessely, S. & Hotopf, M. The relationship between prior psychiatric disorder and chronic fatigue: evidence from a national birth cohort study. Psychol. Med. 38, 933-940 (2008).
    • (2008) Psychol. Med. , vol.38 , pp. 933-940
    • Harvey, S.B.1    Wadsworth, M.2    Wessely, S.3    Hotopf, M.4
  • 22
    • 0003472502 scopus 로고    scopus 로고
    • American Psychiatric Association. 5th edn (American Psychiatric Publishing
    • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5th edn (American Psychiatric Publishing, 2013).
    • (2013) Diagnostic and Statistical Manual of Mental Disorders
  • 23
    • 84983393043 scopus 로고    scopus 로고
    • Co occurrence and symptomatology of fatigue and depression
    • Corfield, E. C., Martin, N. G. & Nyholt, D. R. Co occurrence and symptomatology of fatigue and depression. Compr. Psychiatry 71, 1-10 (2016).
    • (2016) Compr. Psychiatry , vol.71 , pp. 1-10
    • Corfield, E.C.1    Martin, N.G.2    Nyholt, D.R.3
  • 24
    • 0034904033 scopus 로고    scopus 로고
    • Epidemiology of unexplained fatigue and major depression in the community: The Baltimore ECA follow up, 1981-1994
    • Addington, A. M., Gallo, J. J., Ford, D. E. & Eaton, W. W. Epidemiology of unexplained fatigue and major depression in the community: The Baltimore ECA follow up, 1981-1994. Psychol. Med. 31, 1037-1044 (2001).
    • (2001) Psychol. Med. , vol.31 , pp. 1037-1044
    • Addington, A.M.1    Gallo, J.J.2    Ford, D.E.3    Eaton, W.W.4
  • 25
    • 0042307335 scopus 로고    scopus 로고
    • Serotonin and the neuroendocrine regulation of the hypothalamic-pituitary-adrenal axis in health and disease
    • Hanley, N. S. & Van de Kar, L. D. Serotonin and the neuroendocrine regulation of the hypothalamic-pituitary-adrenal axis in health and disease. Vitam. Horm. 66, 189-255 (2003).
    • (2003) Vitam. Horm. , vol.66 , pp. 189-255
    • Hanley, N.S.1    Van De Kar, L.D.2
  • 26
    • 84947875160 scopus 로고    scopus 로고
    • Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease
    • Qamhawi, Z. et al. Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease. Brain 138, 2964-2973 (2015).
    • (2015) Brain , vol.138 , pp. 2964-2973
    • Qamhawi, Z.1
  • 28
    • 37249094173 scopus 로고    scopus 로고
    • From inflammation to sickness and depression: When the immune system subjugates the brain
    • Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W. & Kelley, K. W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9, 46-56 (2008).
    • (2008) Nat. Rev. Neurosci. , vol.9 , pp. 46-56
    • Dantzer, R.1    O'Connor, J.C.2    Freund, G.G.3    Johnson, R.W.4    Kelley, K.W.5
  • 29
    • 68049131222 scopus 로고    scopus 로고
    • Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity
    • Harrison, N. A. et al. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol. Psychiatry 66, 407-414 (2009).
    • (2009) Biol. Psychiatry , vol.66 , pp. 407-414
    • Harrison, N.A.1
  • 30
    • 84920933457 scopus 로고    scopus 로고
    • The representation of inflammatory signals in the brain -a model for subjective fatigue in multiple sclerosis
    • Hanken, K., Eling, P. & Hildebrandt, H. The representation of inflammatory signals in the brain -a model for subjective fatigue in multiple sclerosis. Front. Neurol. 5, 264 (2014).
    • (2014) Front. Neurol. , vol.5 , pp. 264
    • Hanken, K.1    Eling, P.2    Hildebrandt, H.3
  • 31
    • 84998854189 scopus 로고    scopus 로고
    • The Berlin treatment algorithm Recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue
    • Veauthier, C. The Berlin treatment algorithm. Recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue. EPMA J. 7, 25 (2016).
    • (2016) EPMA J. , vol.7 , pp. 25
    • Veauthier, C.1
  • 32
    • 79959864896 scopus 로고    scopus 로고
    • Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression
    • Gold, S. M. et al. Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression. J. Neurol. Neurosurg. Psychiatry 82, 814-818 (2011).
    • (2011) J. Neurol. Neurosurg. Psychiatry , vol.82 , pp. 814-818
    • Gold, S.M.1
  • 33
    • 84927702971 scopus 로고    scopus 로고
    • Circadian cortisol and fatigue severity in relapsing-remitting multiple sclerosis
    • Powell, D. J. H., Moss-Morris, R., Liossi, C. & Schlotz, W. Circadian cortisol and fatigue severity in relapsing-remitting multiple sclerosis. Psychoneuroendocrinology 56, 120-131 (2015).
    • (2015) Psychoneuroendocrinology , vol.56 , pp. 120-131
    • Powell, D.J.H.1    Moss-Morris, R.2    Liossi, C.3    Schlotz, W.4
  • 34
    • 77950885206 scopus 로고    scopus 로고
    • Relationship of cortical atrophy to fatigue in patients with multiple sclerosis
    • Pellicano, C. et al. Relationship of cortical atrophy to fatigue in patients with multiple sclerosis. Arch. Neurol. 67, 447-453 (2010).
    • (2010) Arch. Neurol. , vol.67 , pp. 447-453
    • Pellicano, C.1
  • 35
    • 83255186679 scopus 로고    scopus 로고
    • Fatigue and progression of corpus callosum atrophy in multiple sclerosis
    • Yaldizli, Ö. et al. Fatigue and progression of corpus callosum atrophy in multiple sclerosis. J. Neurol. 258, 2199-2205 (2011).
    • (2011) J. Neurol. , vol.258 , pp. 2199-2205
    • Yaldizli, Ö.1
  • 36
    • 84895743885 scopus 로고    scopus 로고
    • The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients
    • Yaldizli, Ö. et al. The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients. Mult. Scler. 20, 356-364 (2014).
    • (2014) Mult. Scler. , vol.20 , pp. 356-364
    • Yaldizli, Ö.1
  • 37
    • 84992111568 scopus 로고    scopus 로고
    • The impact of MS related cognitive fatigue on future brain parenchymal loss and relapse: A 17 month follow up study
    • Sander, C. et al. The impact of MS related cognitive fatigue on future brain parenchymal loss and relapse: A 17 month follow up study. Front. Neurol. 7, 155 (2016).
    • (2016) Front. Neurol. , vol.7 , pp. 155
    • Sander, C.1
  • 38
    • 61849169991 scopus 로고    scopus 로고
    • Fatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathways
    • Sepulcre, J. et al. Fatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathways. Mult. Scler. 15, 337-344 (2008).
    • (2008) Mult. Scler. , vol.15 , pp. 337-344
    • Sepulcre, J.1
  • 39
    • 77953739225 scopus 로고    scopus 로고
    • Frontal networks play a role in fatigue perception in multiple sclerosis
    • Pardini, M., Bonzano, L., Mancardi, G. L. & Roccatagliata, L. Frontal networks play a role in fatigue perception in multiple sclerosis. Behav. Neurosci. 124, 329 (2010).
    • (2010) Behav. Neurosci. , vol.124 , pp. 329
    • Pardini, M.1    Bonzano, L.2    Mancardi, G.L.3    Roccatagliata, L.4
  • 40
    • 85007566083 scopus 로고    scopus 로고
    • Abnormal resting-state neural activity and connectivity of fatigue in Parkinson's disease
    • Zhang, J. J. et al. Abnormal resting-state neural activity and connectivity of fatigue in Parkinson's disease. CNS Neurosci. Ther. 23, 241-247 (2017).
    • (2017) CNS Neurosci. Ther. , vol.23 , pp. 241-247
    • Zhang, J.J.1
  • 41
    • 84994626508 scopus 로고    scopus 로고
    • Hyperconnectivity of the dorsolateral prefrontal cortex following mental effort in multiple sclerosis patients with cognitive fatigue
    • Pravatà, E. et al. Hyperconnectivity of the dorsolateral prefrontal cortex following mental effort in multiple sclerosis patients with cognitive fatigue. Mult. Scler. 13, 1665-1675 (2016).
    • (2016) Mult. Scler. , vol.13 , pp. 1665-1675
    • Pravatà, E.1
  • 42
    • 84930386562 scopus 로고    scopus 로고
    • Altered basal ganglia functional connectivity in multiple sclerosis patients with fatigue
    • Finke, C. et al. Altered basal ganglia functional connectivity in multiple sclerosis patients with fatigue. Mult. Scler. 21, 925-934 (2015).
    • (2015) Mult. Scler. , vol.21 , pp. 925-934
    • Finke, C.1
  • 43
    • 84935909672 scopus 로고    scopus 로고
    • Factors associated with poststroke fatigue: A systematic review
    • Ponchel, A., Bombois, S., Bordet, R. & Hénon, H. Factors associated with poststroke fatigue: A systematic review. Stroke Res. Treat. 2015, 347920 (2015).
    • (2015) Stroke Res. Treat. , vol.2015 , pp. 347920
    • Ponchel, A.1    Bombois, S.2    Bordet, R.3    Hénon, H.4
  • 44
    • 84929287206 scopus 로고    scopus 로고
    • Model of understanding fatigue after stroke
    • Wu, S., Mead, G., Macleod, M. & Chalder, T. Model of understanding fatigue after stroke. Stroke 46, 893-898 (2015).
    • (2015) Stroke , vol.46 , pp. 893-898
    • Wu, S.1    Mead, G.2    Macleod, M.3    Chalder, T.4
  • 45
    • 84880135284 scopus 로고    scopus 로고
    • Fatigue is associated with metabolic and density alterations of cortical and deep gray matter in relapsing-remitting-multiple sclerosis patients at the earlier stage of the disease: A PET/MR study
    • Derache, N. et al. Fatigue is associated with metabolic and density alterations of cortical and deep gray matter in relapsing-remitting-multiple sclerosis patients at the earlier stage of the disease: A PET/MR study. Mult. Scler. Relat. Disord. 2, 362-369 (2013).
    • (2013) Mult. Scler. Relat. Disord. , vol.2 , pp. 362-369
    • Derache, N.1
  • 46
    • 84926504978 scopus 로고    scopus 로고
    • The dopamine imbalance hypothesis of fatigue in multiple sclerosis and other neurological disorders
    • Dobryakova, E., Genova, H. M., DeLuca, J. & Wylie, G. R. The dopamine imbalance hypothesis of fatigue in multiple sclerosis and other neurological disorders. Front. Neurol. 6, 52 (2015).
    • (2015) Front. Neurol. , vol.6 , pp. 52
    • Dobryakova, E.1    Genova, H.M.2    DeLuca, J.3    Wylie, G.R.4
  • 47
    • 0024420189 scopus 로고
    • The fatigue severity scale: Application to patients with multiple sclerosis and systemic lupus erythematosus
    • Krupp, L. B., LaRocca, N. G., Muir-Nash, J. & Steinberg, A. D. The fatigue severity scale: Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch. Neurol. 46, 1121-1123 (1989).
    • (1989) Arch. Neurol. , vol.46 , pp. 1121-1123
    • Krupp, L.B.1    LaRocca, N.G.2    Muir-Nash, J.3    Steinberg, A.D.4
  • 48
    • 0034094589 scopus 로고    scopus 로고
    • Fatigue in multiple sclerosis and its relationship to depression and neurologic disability
    • Bakshi, R. et al. Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult. Scler. 6, 181-185 (2000).
    • (2000) Mult. Scler. , vol.6 , pp. 181-185
    • Bakshi, R.1
  • 49
    • 18744380337 scopus 로고    scopus 로고
    • Fatigue in multiple sclerosis: A comparison of different rating scales and correlation to clinical parameters
    • Flachenecker, P. et al. Fatigue in multiple sclerosis: A comparison of different rating scales and correlation to clinical parameters. Mult. Scler. 8, 523-526 (2002).
    • (2002) Mult. Scler. , vol.8 , pp. 523-526
    • Flachenecker, P.1
  • 50
    • 84864041869 scopus 로고    scopus 로고
    • Self-report fatigue questionnaires in multiple sclerosis, Parkinson's disease and stroke: A systematic review of measurement properties
    • Elbers, R. G. et al. Self-report fatigue questionnaires in multiple sclerosis, Parkinson's disease and stroke: A systematic review of measurement properties. Qual. Life Res. 21, 925-944 (2012).
    • (2012) Qual. Life Res. , vol.21 , pp. 925-944
    • Elbers, R.G.1
  • 52
    • 15544386641 scopus 로고    scopus 로고
    • Does the modified fatigue impact scale offer a more comprehensive assessment of fatigue in MS
    • Téllez, N. et al. Does the modified fatigue impact scale offer a more comprehensive assessment of fatigue in MS Mult. Scler. 11, 198-202 (2005).
    • (2005) Mult. Scler. , vol.11 , pp. 198-202
    • Téllez, N.1
  • 53
    • 72749087539 scopus 로고    scopus 로고
    • The fatigue scale for motor and cognitive functions (FSMC): Validation of a new instrument to assess multiple sclerosis-related fatigue
    • Penner, I. K. et al. The fatigue scale for motor and cognitive functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue. Mult. Scler. 15, 1509-1517 (2009).
    • (2009) Mult. Scler. , vol.15 , pp. 1509-1517
    • Penner, I.K.1
  • 54
    • 84861218069 scopus 로고    scopus 로고
    • Assessment of post-stroke fatigue: The fatigue scale for motor and cognitive functions
    • Hubacher, M. et al. Assessment of post-stroke fatigue: The fatigue scale for motor and cognitive functions. Eur. Neurol. 67, 377-384 (2012).
    • (2012) Eur. Neurol. , vol.67 , pp. 377-384
    • Hubacher, M.1
  • 55
    • 84934343192 scopus 로고    scopus 로고
    • Increased TH17/TReg ratio in poststroke fatigue
    • Liu, X. et al. Increased TH17/TReg ratio in poststroke fatigue. Mediators Inflamm. 2015, 931398 (2015).
    • (2015) Mediators Inflamm. , vol.2015 , pp. 931398
    • Liu, X.1
  • 58
    • 0028822583 scopus 로고
    • Fatigue in MS is associated with specific clinical features
    • Colosimo, C. et al. Fatigue in MS is associated with specific clinical features. Acta Neurol. Scand. 92, 353-355 (1995).
    • (1995) Acta Neurol. Scand. , vol.92 , pp. 353-355
    • Colosimo, C.1
  • 59
    • 0035077361 scopus 로고    scopus 로고
    • Physiopathology and treatment of fatigue in multiple sclerosis
    • Comi, G., Leocani, L., Rossi, P. & Colombo, B. Physiopathology and treatment of fatigue in multiple sclerosis. J. Neurol. 248, 174-179 (2001).
    • (2001) J. Neurol. , vol.248 , pp. 174-179
    • Comi, G.1    Leocani, L.2    Rossi, P.3    Colombo, B.4
  • 60
    • 0034750269 scopus 로고    scopus 로고
    • Quality of life in multiple sclerosis: The impact of depression, fatigue and disability
    • Amato, M. P. et al. Quality of life in multiple sclerosis: The impact of depression, fatigue and disability. Mult. Scler. 7, 340-344 (2001).
    • (2001) Mult. Scler. , vol.7 , pp. 340-344
    • Amato, M.P.1
  • 61
    • 84874940265 scopus 로고    scopus 로고
    • Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: A cross-sectional study
    • Flensner, G., Landtblom, A. M., Söderhamn, O. & Ek, A. C. Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: A cross-sectional study. BMC Public Health 13, 224 (2013).
    • (2013) BMC Public Health , vol.13 , pp. 224
    • Flensner, G.1    Landtblom, A.M.2    Söderhamn, O.3    Ek, A.C.4
  • 63
    • 80053451412 scopus 로고    scopus 로고
    • The relationship between fatigue and other clinical features of multiple sclerosis
    • Mills, R. J. & Young, C. A. The relationship between fatigue and other clinical features of multiple sclerosis. Mult. Scler. 17, 604-612 (2011).
    • (2011) Mult. Scler. , vol.17 , pp. 604-612
    • Mills, R.J.1    Young, C.A.2
  • 64
    • 84856722766 scopus 로고    scopus 로고
    • Fatigue in multiple sclerosis: Which patient should be referred to a sleep specialist
    • Veauthier, C. & Paul, F. Fatigue in multiple sclerosis: which patient should be referred to a sleep specialist Mult. Scler. 18, 248-249 (2012).
    • (2012) Mult. Scler. , vol.18 , pp. 248-249
    • Veauthier, C.1    Paul, F.2
  • 65
    • 84891628450 scopus 로고    scopus 로고
    • Sleep disorders in multiple sclerosis and their relationship to fatigue
    • Veauthier, C. & Paul, F. Sleep disorders in multiple sclerosis and their relationship to fatigue. Sleep Med. 15, 5-14 (2014).
    • (2014) Sleep Med. , vol.15 , pp. 5-14
    • Veauthier, C.1    Paul, F.2
  • 66
    • 84979223208 scopus 로고    scopus 로고
    • Therapy of fatigue in multiple sclerosis: A treatment algorithm [German]
    • Veauthier, C. & Paul, F. Therapy of fatigue in multiple sclerosis: A treatment algorithm [German]. Nervenarzt 87, 1310-1321 (2016).
    • (2016) Nervenarzt , vol.87 , pp. 1310-1321
    • Veauthier, C.1    Paul, F.2
  • 67
    • 84941901406 scopus 로고    scopus 로고
    • Pharmacological treatments for fatigue associated with palliative care
    • Mücke, M. et al. Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst. Rev. 5, CD006788 (2015).
    • (2015) Cochrane Database Syst. Rev. , vol.5 , pp. CD006788
    • Mücke, M.1
  • 68
    • 84907944162 scopus 로고    scopus 로고
    • Meta-analysis of three different types of fatigue management interventions for people with multiple sclerosis: Exercise, education, and medication
    • Asano, M. & Finlayson, M. L. Meta-analysis of three different types of fatigue management interventions for people with multiple sclerosis: exercise, education, and medication. Mult. Scler. Int. 2014, 798285 (2014).
    • (2014) Mult. Scler. Int. , vol.2014 , pp. 798285
    • Asano, M.1    Finlayson, M.L.2
  • 70
    • 84963751173 scopus 로고    scopus 로고
    • Fatigue management in multiple sclerosis
    • Tur, C. Fatigue management in multiple sclerosis. Curr. Treat. Options Neurol. 18, 26 (2016).
    • (2016) Curr. Treat. Options Neurol. , vol.18 , pp. 26
    • Tur, C.1
  • 71
    • 84984833776 scopus 로고    scopus 로고
    • Fatigue and depression in multiple sclerosis: Pharmacological and non-pharmacological interventions
    • Brenner, P. & Piehl, F. Fatigue and depression in multiple sclerosis: pharmacological and non-pharmacological interventions. Acta Neurol. Scand. 134, 47-54 (2016).
    • (2016) Acta Neurol. Scand. , vol.134 , pp. 47-54
    • Brenner, P.1    Piehl, F.2
  • 72
    • 0023231728 scopus 로고
    • A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis
    • Hader, W. et al. A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis. Can. J. Neurol. Sci. 14, 273-278 (1987).
    • (1987) Can. J. Neurol. Sci. , vol.14 , pp. 273-278
    • Hader, W.1
  • 73
    • 0024340480 scopus 로고
    • Amantadine treatment of fatigue associated with multiple sclerosis
    • Cohen, R. A. & Fisher, M. Amantadine treatment of fatigue associated with multiple sclerosis. Arch. Neurol. 46, 676-680 (1989).
    • (1989) Arch. Neurol. , vol.46 , pp. 676-680
    • Cohen, R.A.1    Fisher, M.2
  • 74
    • 84890054444 scopus 로고    scopus 로고
    • Evaluating the effects of amantadin, modafinil and acetyl-l carnitine on fatigue in multiple sclerosis -result of a pilot randomized, blind study
    • Ledinek, A. H., Sajko, M. C. & Rot, U. Evaluating the effects of amantadin, modafinil and acetyl-l carnitine on fatigue in multiple sclerosis -result of a pilot randomized, blind study. Clin. Neurol. Neurosurg. 115 (Suppl. 1), S86-S89 (2013).
    • (2013) Clin. Neurol. Neurosurg. , vol.115 , pp. S86-S89
    • Ledinek, A.H.1    Sajko, M.C.2    Rot, U.3
  • 75
    • 0030019643 scopus 로고    scopus 로고
    • The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis
    • Geisler, M. W. et al. The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis. Arch. Neurol. 53, 185-188 (1996).
    • (1996) Arch. Neurol. , vol.53 , pp. 185-188
    • Geisler, M.W.1
  • 76
    • 0029400839 scopus 로고
    • Fatigue therapy in multiple sclerosis: Results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo
    • Krupp, L. B. et al. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. Neurology 45, 1956-1961 (1995).
    • (1995) Neurology , vol.45 , pp. 1956-1961
    • Krupp, L.B.1
  • 77
    • 0022257683 scopus 로고
    • Amantadine therapy for fatigue in multiple sclerosis
    • Murray, T. J. Amantadine therapy for fatigue in multiple sclerosis. Can. J. Neurol. Sci. 12, 251-254 (1985).
    • (1985) Can. J. Neurol. Sci. , vol.12 , pp. 251-254
    • Murray, T.J.1
  • 78
    • 0023773366 scopus 로고
    • Amantadine, fatigue, and multiple sclerosis
    • Rosenberg, G. A. & Appenzeller, O. Amantadine, fatigue, and multiple sclerosis. Arch. Neurol. 45, 1104-1106 (1988).
    • (1988) Arch. Neurol. , vol.45 , pp. 1104-1106
    • Rosenberg, G.A.1    Appenzeller, O.2
  • 79
    • 70449642846 scopus 로고    scopus 로고
    • Does amantadine have favourable effects on fatigue in Persian patients suffering from multiple sclerosis
    • Ashtari, F., Fatehi, F., Shaygannejad, V. & Chitsaz, A. Does amantadine have favourable effects on fatigue in Persian patients suffering from multiple sclerosis Neurol. Neurochir. Pol. 43, 428-432 (2009).
    • (2009) Neurol Neurochir Pol. , vol.43 , pp. 428-432
    • Ashtari, F.1    Fatehi, F.2    Shaygannejad, V.3    Chitsaz, A.4
  • 80
    • 84867915848 scopus 로고    scopus 로고
    • Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: A randomized, blinded, crossover study
    • Shaygannejad, V., Janghorbani, M., Ashtari, F. & Zakeri, H. Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: A randomized, blinded, crossover study. Neurol. Res. 34, 854-858 (2012).
    • (2012) Neurol. Res. , vol.34 , pp. 854-858
    • Shaygannejad, V.1    Janghorbani, M.2    Ashtari, F.3    Zakeri, H.4
  • 81
    • 37049017697 scopus 로고    scopus 로고
    • Amantadine for fatigue in multiple sclerosis
    • Pucci, E. et al. Amantadine for fatigue in multiple sclerosis. Cochrane Database Syst. Rev. 1, CD002818 (2007).
    • (2007) Cochrane Database Syst. Rev. , vol.1 , pp. CD002818
    • Pucci, E.1
  • 83
    • 52449091605 scopus 로고    scopus 로고
    • Effects of glatiramer acetate on fatigue and days of absence from work in first-time treated relapsing-remitting multiple sclerosis
    • Ziemssen, T., Hoffman, J., Apfel, R. & Kern, S. Effects of glatiramer acetate on fatigue and days of absence from work in first-time treated relapsing-remitting multiple sclerosis. Health Qual. Life Outcomes 6, 67 (2008).
    • (2008) Health Qual. Life Outcomes , vol.6 , pp. 67
    • Ziemssen, T.1    Hoffman, J.2    Apfel, R.3    Kern, S.4
  • 84
    • 69549130717 scopus 로고    scopus 로고
    • Multiple sclerosis associated fatigue during natalizumab treatment
    • Putzki, N., Yaldizli, Ö., Tettenborn, B. & Diener, H. C. Multiple sclerosis associated fatigue during natalizumab treatment. J. Neurol. Sci. 285, 109-113 (2009).
    • (2009) J. Neurol. Sci. , vol.285 , pp. 109-113
    • Putzki, N.1    Yaldizli, Ö.2    Tettenborn, B.3    Diener, H.C.4
  • 85
    • 79953185078 scopus 로고    scopus 로고
    • Multiple sclerosis-associated fatigue during disease-modifying treatment with natalizumab, interferon and glatiramer acetate
    • Yildiz, M., Tettenborn, B. & Putzki, N. Multiple sclerosis-associated fatigue during disease-modifying treatment with natalizumab, interferon and glatiramer acetate. Eur. Neurol. 65, 231-232 (2011).
    • (2011) Eur. Neurol. , vol.65 , pp. 231-232
    • Yildiz, M.1    Tettenborn, B.2    Putzki, N.3
  • 86
    • 84866177950 scopus 로고    scopus 로고
    • Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: A prospective, open-label, two years observational study
    • Iaffaldano, P. et al. Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: A prospective, open-label, two years observational study. PLoS ONE 7, e35843 (2012).
    • (2012) PLoS ONE , vol.7 , pp. e35843
    • Iaffaldano, P.1
  • 87
    • 84875281260 scopus 로고    scopus 로고
    • Natalizumab treatment reduces fatigue in multiple sclerosis Results from the TYNERGY trial; A study in the real life setting
    • Svenningsson, A. et al. Natalizumab treatment reduces fatigue in multiple sclerosis. Results from the TYNERGY trial; a study in the real life setting. PLoS ONE 8, e58643 (2013).
    • (2013) PLoS ONE , vol.8 , pp. e58643
    • Svenningsson, A.1
  • 88
    • 84894271594 scopus 로고    scopus 로고
    • Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): A randomised, double-blind, placebo-controlled, phase 3 trial
    • Confavreux, C. et al. Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): A randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol. 13, 247-256 (2014).
    • (2014) Lancet Neurol. , vol.13 , pp. 247-256
    • Confavreux, C.1
  • 89
    • 84897022266 scopus 로고    scopus 로고
    • Teriflunomide versus subcutaneous interferon 1a in patients with relapsing multiple sclerosis: A randomised, controlled phase 3 trial
    • Vermersch, P. et al. Teriflunomide versus subcutaneous interferon 1a in patients with relapsing multiple sclerosis: A randomised, controlled phase 3 trial. Mult. Scler. 20, 705-716 (2014).
    • (2014) Mult. Scler. , vol.20 , pp. 705-716
    • Vermersch, P.1
  • 90
    • 79951946144 scopus 로고    scopus 로고
    • Sensitivity to heat in MS patients: A factor strongly influencing symptomology -an explorative survey
    • Flensner, G., Ek, A. C., Söderhamn, O. & Landtblom, A. M. Sensitivity to heat in MS patients: A factor strongly influencing symptomology -an explorative survey. BMC Neurol. 11, 27 (2011).
    • (2011) BMC Neurol. , vol.11 , pp. 27
    • Flensner, G.1    Ek, A.C.2    Söderhamn, O.3    Landtblom, A.M.4
  • 91
    • 0038714573 scopus 로고    scopus 로고
    • A randomized controlled study of the acute and chronic effects of cooling therapy for MS
    • Schwid, S. R. et al. A randomized controlled study of the acute and chronic effects of cooling therapy for MS. Neurology 60, 1955-1960 (2003).
    • (2003) Neurology , vol.60 , pp. 1955-1960
    • Schwid, S.R.1
  • 92
    • 84955079530 scopus 로고    scopus 로고
    • Whole-body cryostimulation (cryotherapy) provides benefits for fatigue and functional status in multiple sclerosis patients. A case-control study
    • Miller, E., Kostka, J., Wodarczyk, T. & Dugué, B. Whole-body cryostimulation (cryotherapy) provides benefits for fatigue and functional status in multiple sclerosis patients. A case-control study. Acta Neurol. Scand. 134, 420-426 (2016).
    • (2016) Acta Neurol. Scand. , vol.134 , pp. 420-426
    • Miller, E.1    Kostka, J.2    Wodarczyk, T.3    Dugué, B.4
  • 93
    • 21644452131 scopus 로고    scopus 로고
    • Relaxation and health-related quality of life in multiple sclerosis: The example of autogenic training
    • Sutherland, G., Andersen, M. B. & Morris, T. Relaxation and health-related quality of life in multiple sclerosis: The example of autogenic training. J. Behav. Med. 28, 249-256 (2005).
    • (2005) J. Behav. Med. , vol.28 , pp. 249-256
    • Sutherland, G.1    Andersen, M.B.2    Morris, T.3
  • 94
    • 84867538376 scopus 로고    scopus 로고
    • Evaluation of the effect of progressive relaxation exercises on fatigue and sleep quality in patients with multiple sclerosis
    • Dayapolu, N. & Tan, M. Evaluation of the effect of progressive relaxation exercises on fatigue and sleep quality in patients with multiple sclerosis. J. Altern. Complement. Med. 18, 983-987 (2012).
    • (2012) J. Altern. Complement. Med. , vol.18 , pp. 983-987
    • Dayapolu, N.1    Tan, M.2
  • 95
    • 84983371734 scopus 로고    scopus 로고
    • The self-directed biological transformation initiative and well-being
    • Mills, P. J. et al. The self-directed biological transformation initiative and well-being. J. Altern. Complement. Med. 22, 627-634 (2016).
    • (2016) J. Altern. Complement. Med. , vol.22 , pp. 627-634
    • Mills, P.J.1
  • 96
    • 2942538466 scopus 로고    scopus 로고
    • Randomized controlled trial of yoga and exercise in multiple sclerosis
    • Oken, B. S. et al. Randomized controlled trial of yoga and exercise in multiple sclerosis. Neurology 62, 2058-2064 (2004).
    • (2004) Neurology , vol.62 , pp. 2058-2064
    • Oken, B.S.1
  • 97
    • 77955658183 scopus 로고    scopus 로고
    • Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis
    • Velikonja, O., uric, K., Ožura, A. & Jazbec, S. Š. Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis. Clin. Neurol. Neurosurg. 112, 597-601 (2010).
    • (2010) Clin. Neurol. Neurosurg. , vol.112 , pp. 597-601
    • Velikonja, O.1    Uric, K.2    Ožura, A.3    Jazbec, S.Š.4
  • 98
    • 84949845279 scopus 로고    scopus 로고
    • Exercising impacts on fatigue, depression, and paresthesia in female patients with multiple sclerosis
    • Razazian, N. et al. Exercising impacts on fatigue, depression, and paresthesia in female patients with multiple sclerosis. Med. Sci. Sports Exerc. 48, 796-803 (2016).
    • (2016) Med. Sci. Sports Exerc. , vol.48 , pp. 796-803
    • Razazian, N.1
  • 99
    • 84860390114 scopus 로고    scopus 로고
    • The effect of exercise therapy on fatigue in multiple sclerosis
    • Andreasen, A. K., Stenager, E. & Dalgas, U. The effect of exercise therapy on fatigue in multiple sclerosis. Mult. Scler. 17, 1041-1054 (2011).
    • (2011) Mult. Scler. , vol.17 , pp. 1041-1054
    • Andreasen, A.K.1    Stenager, E.2    Dalgas, U.3
  • 100
    • 0036200218 scopus 로고    scopus 로고
    • Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis
    • Mostert, S. & Kesselring, J. Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis. Mult. Scler. 8, 161-168 (2002).
    • (2002) Mult. Scler. , vol.8 , pp. 161-168
    • Mostert, S.1    Kesselring, J.2
  • 101
    • 70349771199 scopus 로고    scopus 로고
    • Comparing individualized rehabilitation to a group wellness intervention for persons with multiple sclerosis
    • Plow, M. A., Mathiowetz, V. & Lowe, D. A. Comparing individualized rehabilitation to a group wellness intervention for persons with multiple sclerosis. Am. J. Health Promot. 24, 23-26 (2009).
    • (2009) Am. J. Health Promot. , vol.24 , pp. 23-26
    • Plow, M.A.1    Mathiowetz, V.2    Lowe, D.A.3
  • 102
    • 41549125860 scopus 로고    scopus 로고
    • Long-term benefits of exercising on quality of life and fatigue in multiple sclerosis patients with mild disability: A pilot study
    • McCullagh, R., Fitzgerald, A. P., Murphy, R. P. & Cooke, G. Long-term benefits of exercising on quality of life and fatigue in multiple sclerosis patients with mild disability: A pilot study. Clin. Rehabil. 22, 206-214 (2008).
    • (2008) Clin. Rehabil. , vol.22 , pp. 206-214
    • McCullagh, R.1    Fitzgerald, A.P.2    Murphy, R.P.3    Cooke, G.4
  • 103
    • 77954661488 scopus 로고    scopus 로고
    • Fatigue, mood and quality of life improve in MS patients after progressive resistance training
    • Dalgas, U. et al. Fatigue, mood and quality of life improve in MS patients after progressive resistance training. Mult. Scler. 16, 480-490 (2010).
    • (2010) Mult. Scler. , vol.16 , pp. 480-490
    • Dalgas, U.1
  • 104
    • 84866368728 scopus 로고    scopus 로고
    • Effect of aquatic exercise training on fatigue and health-related quality of life in patients with multiple sclerosis
    • Kargarfard, M., Etemadifar, M., Baker, P., Mehrabi, M. & Hayatbakhsh, R. Effect of aquatic exercise training on fatigue and health-related quality of life in patients with multiple sclerosis. Arch. Phys. Med. Rehabil. 93, 1701-1708 (2012).
    • (2012) Arch. Phys. Med. Rehabil. , vol.93 , pp. 1701-1708
    • Kargarfard, M.1    Etemadifar, M.2    Baker, P.3    Mehrabi, M.4    Hayatbakhsh, R.5
  • 105
    • 84876546570 scopus 로고    scopus 로고
    • Training in MS: Influence of two different endurance training protocols (aquatic versus overland) on cytokine and neurotrophin concentrations during three week randomized controlled trial
    • Bansi, J., Bloch, W., Gamper, U. & Kesselring, J. Training in MS: influence of two different endurance training protocols (aquatic versus overland) on cytokine and neurotrophin concentrations during three week randomized controlled trial. Mult. Scler. 19, 613-621 (2012).
    • (2012) Mult. Scler. , vol.19 , pp. 613-621
    • Bansi, J.1    Bloch, W.2    Gamper, U.3    Kesselring, J.4
  • 107
    • 39149138967 scopus 로고    scopus 로고
    • A randomized controlled trial of cognitive behavior therapy for multiple sclerosis fatigue
    • van Kessel, K. et al. A randomized controlled trial of cognitive behavior therapy for multiple sclerosis fatigue. Psychosom. Med. 70, 205-213 (2008).
    • (2008) Psychosom. Med. , vol.70 , pp. 205-213
    • Van Kessel, K.1
  • 108
    • 85032458719 scopus 로고    scopus 로고
    • Online fatigue management program for patients with multiple sclerosis -a randomized controlled trial
    • Poettgen, J. et al. Online fatigue management program for patients with multiple sclerosis -a randomized controlled trial. Mult. Scler. 21, 41-42 (2015).
    • (2015) Mult. Scler. , vol.21 , pp. 41-42
    • Poettgen, J.1
  • 109
    • 84877276124 scopus 로고    scopus 로고
    • Treatment of fatigue in multiple sclerosis patients: A neurocognitive approach
    • Catalan, M. et al. Treatment of fatigue in multiple sclerosis patients: A neurocognitive approach. Rehabil. Res. Pract. 2011, 670537 (2011).
    • (2011) Rehabil. Res. Pract. , vol.2011 , pp. 670537
    • Catalan, M.1
  • 110
    • 77957946229 scopus 로고    scopus 로고
    • MS quality of life, depression, and fatigue improve after mindfulness training: A randomized trial
    • Grossman, P. et al. MS quality of life, depression, and fatigue improve after mindfulness training: A randomized trial. Neurology 75, 1141-1149 (2010).
    • (2010) Neurology , vol.75 , pp. 1141-1149
    • Grossman, P.1
  • 112
    • 68149164576 scopus 로고    scopus 로고
    • Working memory training in patients with multiple sclerosis -comparison of two different training schedules
    • Vogt, A. et al. Working memory training in patients with multiple sclerosis -comparison of two different training schedules. Restor. Neurol. Neurosci. 27, 225-235 (2009).
    • (2009) Restor. Neurol. Neurosci. , vol.27 , pp. 225-235
    • Vogt, A.1
  • 113
    • 84975317311 scopus 로고    scopus 로고
    • Inflammation and the silent sequelae of stroke
    • Becker, K. J. Inflammation and the silent sequelae of stroke. Neurotherapeutics 13, 801-810 (2016).
    • (2016) Neurotherapeutics , vol.13 , pp. 801-810
    • Becker, K.J.1
  • 115
    • 0035174605 scopus 로고    scopus 로고
    • Experience of severe fatigue long after stroke and its relation to depressive symptoms and disease characteristics
    • van der Werf, S. P., van den Broek, H. L., Anten, H. W. & Bleijenberg, G. Experience of severe fatigue long after stroke and its relation to depressive symptoms and disease characteristics. Eur. Neurol. 45, 28-33 (2001).
    • (2001) Eur. Neurol. , vol.45 , pp. 28-33
    • Van Der Werf, S.P.1    Van Den Broek, H.L.2    Anten, H.W.3    Bleijenberg, G.4
  • 116
    • 33846921811 scopus 로고    scopus 로고
    • Fluoxetine is not effective in the treatment of post-stroke fatigue: A double-blind, placebo-controlled study
    • Choi-Kwon, S., Choi, J., Kwon, S. U., Kang, D. W. & Kim, J. S. Fluoxetine is not effective in the treatment of post-stroke fatigue: A double-blind, placebo-controlled study. Cerebrovasc. Dis. 23, 103-108 (2007).
    • (2007) Cerebrovasc. Dis. , vol.23 , pp. 103-108
    • Choi-Kwon, S.1    Choi, J.2    Kwon, S.U.3    Kang, D.W.4    Kim, J.S.5
  • 117
    • 35548964718 scopus 로고    scopus 로고
    • Fatigue after stroke: The development and evaluation of a case definition
    • Lynch, J. et al. Fatigue after stroke: The development and evaluation of a case definition. J. Psychosom. Res. 63, 539-544 (2007).
    • (2007) J. Psychosom. Res. , vol.63 , pp. 539-544
    • Lynch, J.1
  • 118
    • 84862214149 scopus 로고    scopus 로고
    • Frequency and natural history of fatigue after stroke: A systematic review of longitudinal studies
    • Duncan, F., Wu, S. & Mead, G. E. Frequency and natural history of fatigue after stroke: A systematic review of longitudinal studies. J. Psychosom. Res. 73, 18-27 (2012).
    • (2012) J. Psychosom. Res. , vol.73 , pp. 18-27
    • Duncan, F.1    Wu, S.2    Mead, G.E.3
  • 120
    • 77949262388 scopus 로고    scopus 로고
    • Acute basal ganglia infarcts in poststroke fatigue: An MRI study
    • Tang, W. K. et al. Acute basal ganglia infarcts in poststroke fatigue: An MRI study. J. Neurol. 257, 178-182 (2010).
    • (2010) J. Neurol. , vol.257 , pp. 178-182
    • Tang, W.K.1
  • 121
    • 84870896940 scopus 로고    scopus 로고
    • Poststroke fatigue is associated with caudate infarcts
    • Tang, W. K. et al. Poststroke fatigue is associated with caudate infarcts. J. Neurol. Sci. 324, 131-135 (2013).
    • (2013) J. Neurol. Sci. , vol.324 , pp. 131-135
    • Tang, W.K.1
  • 122
    • 14044255786 scopus 로고    scopus 로고
    • Poststroke fatigue: Characteristics and related factors
    • Choi-Kwon, S., Han, S. W., Kwon, S. U. & Kim, J. S. Poststroke fatigue: characteristics and related factors. Cerebrovasc. Dis. 19, 84-90 (2005).
    • (2005) Cerebrovasc. Dis. , vol.19 , pp. 84-90
    • Choi-Kwon, S.1    Han, S.W.2    Kwon, S.U.3    Kim, J.S.4
  • 123
    • 49949118538 scopus 로고    scopus 로고
    • Dimensions of post-stroke fatigue: A two-year follow up study
    • Christensen, D. et al. Dimensions of post-stroke fatigue: A two-year follow up study. Cerebrovasc. Dis. 26, 134-141 (2008).
    • (2008) Cerebrovasc. Dis. , vol.26 , pp. 134-141
    • Christensen, D.1
  • 124
    • 84990239374 scopus 로고    scopus 로고
    • Self-reported fatigue and associated factors six years after stroke
    • Elf, M., Eriksson, G., Johansson, S., von Koch, L. & Ytterberg, C. Self-reported fatigue and associated factors six years after stroke. PLoS ONE 11, e0161942 (2016).
    • (2016) PLoS ONE , vol.11 , pp. e0161942
    • Elf, M.1    Eriksson, G.2    Johansson, S.3    Von Koch, L.4    Ytterberg, C.5
  • 125
    • 68349085674 scopus 로고    scopus 로고
    • Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients
    • Brioschi, A. et al. Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients. Eur. Neurol. 62, 243-249 (2009).
    • (2009) Eur. Neurol. , vol.62 , pp. 243-249
    • Brioschi, A.1
  • 126
    • 84948067409 scopus 로고    scopus 로고
    • Modafinil may alleviate poststroke fatigue: A randomized, placebo-controlled, double-blinded trial
    • Poulsen, M. B., Damgaard, B., Zerahn, B., Overgaard, K. & Rasmussen, R. S. Modafinil may alleviate poststroke fatigue: A randomized, placebo-controlled, double-blinded trial. Stroke 46, 3470-3477 (2015).
    • (2015) Stroke , vol.46 , pp. 3470-3477
    • Poulsen, M.B.1    Damgaard, B.2    Zerahn, B.3    Overgaard, K.4    Rasmussen, R.S.5
  • 127
    • 84982206005 scopus 로고    scopus 로고
    • Modafinil in Debilitating fatigue after Stroke (MIDAS): Study protocol for a randomised, double-blinded, placebo-controlled, crossover trial
    • Lillicrap, T. et al. Modafinil In Debilitating fatigue After Stroke (MIDAS): study protocol for a randomised, double-blinded, placebo-controlled, crossover trial. Trials 17, 410 (2016).
    • (2016) Trials , vol.17 , pp. 410
    • Lillicrap, T.1
  • 128
    • 85017440286 scopus 로고    scopus 로고
    • MIDAS (Modafinil in Debilitating Fatigue after Stroke): A randomized, double-blind, placebo-controlled, cross-over trial
    • Bivard, A. et al. MIDAS (Modafinil in Debilitating Fatigue After Stroke): A randomized, double-blind, placebo-controlled, cross-over trial. Stroke 48, 1293-1298 (2017).
    • (2017) Stroke , vol.48 , pp. 1293-1298
    • Bivard, A.1
  • 130
    • 84990052930 scopus 로고    scopus 로고
    • Post-stroke mood and emotional disturbances: Pharmacological therapy based on mechanisms
    • Kim, J. S. Post-stroke mood and emotional disturbances: pharmacological therapy based on mechanisms. J. Stroke 18, 244-255 (2016).
    • (2016) J. Stroke , vol.18 , pp. 244-255
    • Kim, J.S.1
  • 131
    • 84858849503 scopus 로고    scopus 로고
    • Poststroke fatigue: Does group education make a difference A randomized pilot trial
    • Clarke, A., Barker-Collo, S. L. & Feigin, V. L. Poststroke fatigue: does group education make a difference A randomized pilot trial. Top. Stroke Rehabil. 19, 32-39 (2012).
    • (2012) Top. Stroke Rehabil. , vol.19 , pp. 32-39
    • Clarke, A.1    Barker-Collo, S.L.2    Feigin, V.L.3
  • 132
    • 84859310283 scopus 로고    scopus 로고
    • Cognitive and graded activity training can alleviate persistent fatigue after stroke: A randomized, controlled trial
    • Zedlitz, A. M., Rietveld, T. C., Geurts, A. C. & Fasotti, L. Cognitive and graded activity training can alleviate persistent fatigue after stroke: A randomized, controlled trial. Stroke J. 43, 1046-1051 (2012).
    • (2012) Stroke J. , vol.43 , pp. 1046-1051
    • Zedlitz, A.M.1    Rietveld, T.C.2    Geurts, A.C.3    Fasotti, L.4
  • 133
    • 84869477451 scopus 로고    scopus 로고
    • Mindfulness-based stress reduction (MBSR) improves long-term mental fatigue after stroke or traumatic brain injury
    • Johansson, B., Bjuhr, H. & Rönnbäck, L. Mindfulness-based stress reduction (MBSR) improves long-term mental fatigue after stroke or traumatic brain injury. Brain Inj. 26, 1621-1628 (2012).
    • (2012) Brain Inj. , vol.26 , pp. 1621-1628
    • Johansson, B.1    Bjuhr, H.2    Rönnbäck, L.3
  • 134
    • 8844235607 scopus 로고    scopus 로고
    • Is fatigue an independent and persistent symptom in patients with Parkinson disease
    • Alves, G., Wentzel-Larsen, T. & Larsen, J. P. Is fatigue an independent and persistent symptom in patients with Parkinson disease Neurology 63, 1908-1911 (2004).
    • (2004) Neurology , vol.63 , pp. 1908-1911
    • Alves, G.1    Wentzel-Larsen, T.2    Larsen, J.P.3
  • 135
    • 0036836047 scopus 로고    scopus 로고
    • Measuring fatigue in patients with Parkinson's disease -the fatigue severity scale
    • Herlofson, K. & Larsen, J. P. Measuring fatigue in patients with Parkinson's disease -the fatigue severity scale. Eur. J. Neurol. 9, 595-600 (2002).
    • (2002) Eur. J. Neurol. , vol.9 , pp. 595-600
    • Herlofson, K.1    Larsen, J.P.2
  • 136
    • 41849086277 scopus 로고    scopus 로고
    • Impact of fatigue on quality of life in patients with Parkinson's disease
    • Havlikova, E. et al. Impact of fatigue on quality of life in patients with Parkinson's disease. Eur. J. Neurol. 15, 475-480 (2008).
    • (2008) Eur. J. Neurol. , vol.15 , pp. 475-480
    • Havlikova, E.1
  • 137
    • 77951960974 scopus 로고    scopus 로고
    • Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease
    • Friedman, J. H. et al. Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease. Mov. Disord. 25, 805-822 (2010).
    • (2010) Mov. Disord. , vol.25 , pp. 805-822
    • Friedman, J.H.1
  • 139
    • 84973295214 scopus 로고    scopus 로고
    • Treatment of fatigue in Parkinson disease
    • Elbers, R. G., Berendse, H. W. & Kwakkel, G. Treatment of fatigue in Parkinson disease. JAMA 315, 2340-2341 (2016).
    • (2016) JAMA , vol.315 , pp. 2340-2341
    • Elbers, R.G.1    Berendse, H.W.2    Kwakkel, G.3
  • 140
    • 77952818833 scopus 로고    scopus 로고
    • Central and peripheral fatigue: Exemplified by multiple sclerosis and myasthenia gravis
    • Cantor, F. Central and peripheral fatigue: exemplified by multiple sclerosis and myasthenia gravis. PM R. 2, 399-405 (2010).
    • (2010) PM R. , vol.2 , pp. 399-405
    • Cantor, F.1
  • 141
    • 84986586574 scopus 로고    scopus 로고
    • Muscle strength and fatigue in newly diagnosed patients with myasthenia gravis
    • Vinge, L. & Andersen, H. Muscle strength and fatigue in newly diagnosed patients with myasthenia gravis. Muscle Nerve 54, 709-714 (2016).
    • (2016) Muscle Nerve , vol.54 , pp. 709-714
    • Vinge, L.1    Andersen, H.2
  • 142
    • 84953837822 scopus 로고    scopus 로고
    • Quantitative motor assessment of muscular weakness in myasthenia gravis: A pilot study
    • Hoffmann, S. et al. Quantitative motor assessment of muscular weakness in myasthenia gravis: A pilot study. BMC Neurol. 15, 265 (2015).
    • (2015) BMC Neurol. , vol.15 , pp. 265
    • Hoffmann, S.1
  • 143
    • 84980368667 scopus 로고    scopus 로고
    • International consensus guidance for management of myasthenia gravis: Executive summary
    • Sanders, D. B. et al. International consensus guidance for management of myasthenia gravis: executive summary. Neurology 87, 419-425 (2016).
    • (2016) Neurology , vol.87 , pp. 419-425
    • Sanders, D.B.1
  • 144
    • 0033812353 scopus 로고    scopus 로고
    • Fatigue and its impact on patients with myasthenia gravis
    • Paul, R. H., Cohen, R. A., Goldstein, J. M. & Gilchrist, J. M. Fatigue and its impact on patients with myasthenia gravis. Muscle Nerve 23, 1402-1406 (2000).
    • (2000) Muscle Nerve , vol.23 , pp. 1402-1406
    • Paul, R.H.1    Cohen, R.A.2    Goldstein, J.M.3    Gilchrist, J.M.4
  • 145
  • 146
    • 84884886539 scopus 로고    scopus 로고
    • Fatigue in myasthenia gravis: Is it more than muscular weakness
    • Elsais, A., Wyller, V. B., Loge, J. H. & Kerty, E. Fatigue in myasthenia gravis: is it more than muscular weakness BMC Neurol. 13, 132 (2013).
    • (2013) BMC Neurol. , vol.13 , pp. 132
    • Elsais, A.1    Wyller, V.B.2    Loge, J.H.3    Kerty, E.4
  • 147
    • 0033016944 scopus 로고    scopus 로고
    • The autonomic symptom profile: A new instrument to assess autonomic symptoms
    • Suarez, G. A. et al. The autonomic symptom profile: A new instrument to assess autonomic symptoms. Neurology 52, 523-528 (1999).
    • (1999) Neurology , vol.52 , pp. 523-528
    • Suarez, G.A.1
  • 148
    • 84869490487 scopus 로고    scopus 로고
    • Vitamin D deficiency in patients with myasthenia gravis and improvement of fatigue after supplementation of vitamin D3: A pilot study
    • Askmark, H., Haggrd, L., Nygren, I. & Punga, A. R. Vitamin D deficiency in patients with myasthenia gravis and improvement of fatigue after supplementation of vitamin D3: A pilot study. Eur. J. Neurol. 19, 1554-1560 (2012).
    • (2012) Eur. J. Neurol. , vol.19 , pp. 1554-1560
    • Askmark, H.1    Haggrd, L.2    Nygren, I.3    Punga, A.R.4
  • 149
    • 84870039138 scopus 로고    scopus 로고
    • Fatigue in motor neuron diseases
    • Abraham, A. & Drory, V. E. Fatigue in motor neuron diseases. Neuromuscul. Disord. 22 (Suppl. 3), S198-S202 (2012).
    • (2012) Neuromuscul. Disord. , vol.22 , pp. S198-S202
    • Abraham, A.1    Drory, V.E.2
  • 151
    • 0037435527 scopus 로고    scopus 로고
    • Fatigue and depression are associated with poor quality of life in ALS
    • Lou, J. S., Reeves, A., Benice, T. & Sexton, G. Fatigue and depression are associated with poor quality of life in ALS. Neurology 60, 122-123 (2003).
    • (2003) Neurology , vol.60 , pp. 122-123
    • Lou, J.S.1    Reeves, A.2    Benice, T.3    Sexton, G.4
  • 153
    • 84925872035 scopus 로고    scopus 로고
    • The evidence for symptomatic treatments in amyotrophic lateral sclerosis
    • Jenkins, T. M., Hollinger, H. & McDermott, C. J. The evidence for symptomatic treatments in amyotrophic lateral sclerosis. Curr. Opin. Neurol. 27, 524-531 (2014).
    • (2014) Curr. Opin. Neurol. , vol.27 , pp. 524-531
    • Jenkins, T.M.1    Hollinger, H.2    McDermott, C.J.3
  • 154
    • 13444274616 scopus 로고    scopus 로고
    • Modafinil to treat fatigue in amyotrophic lateral sclerosis: An open label pilot study
    • Carter, G. T. et al. Modafinil to treat fatigue in amyotrophic lateral sclerosis: An open label pilot study. Am. J. Hosp. Palliat. Care 22, 55-59 (2005).
    • (2005) Am. J. Hosp. Palliat. Care , vol.22 , pp. 55-59
    • Carter, G.T.1
  • 155
    • 62849083840 scopus 로고    scopus 로고
    • Modafinil treatment of fatigue in patients with ALS: A placebo-controlled study
    • Rabkin, J. G. et al. Modafinil treatment of fatigue in patients with ALS: A placebo-controlled study. Muscle Nerve 39, 297-303 (2009).
    • (2009) Muscle Nerve , vol.39 , pp. 297-303
    • Rabkin, J.G.1
  • 156
    • 84863111592 scopus 로고    scopus 로고
    • Interventions for fatigue and weight loss in adults with advanced progressive illness
    • Payne, C., Wiffen, P. J. & Martin, S. Interventions for fatigue and weight loss in adults with advanced progressive illness. Cochrane Database Syst. Rev. 1, CD008427 (2012).
    • (2012) Cochrane Database Syst. Rev. , vol.1 , pp. CD008427
    • Payne, C.1    Wiffen, P.J.2    Martin, S.3
  • 157
    • 84897929097 scopus 로고    scopus 로고
    • Neuromyelitis optica: Clinical features, immunopathogenesis and treatment
    • Jarius, S., Wildemann, B. & Paul, F. Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clin. Exp. Immunol. 176, 149-164 (2014).
    • (2014) Clin. Exp. Immunol. , vol.176 , pp. 149-164
    • Jarius, S.1    Wildemann, B.2    Paul, F.3
  • 158
    • 84999127547 scopus 로고    scopus 로고
    • Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis
    • Metz, I. et al. Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis. Neurol. Neuroimmunol. Neuroinflamm. 3, e204 (2016).
    • (2016) Neurol. Neuroimmunol. Neuroinflamm. , vol.3 , pp. e204
    • Metz, I.1
  • 160
    • 84895076673 scopus 로고    scopus 로고
    • Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
    • Trebst, C. et al. Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). J. Neurol. 261, 1-16 (2014).
    • (2014) J. Neurol. , vol.261 , pp. 1-16
    • Trebst, C.1
  • 161
    • 79955737559 scopus 로고    scopus 로고
    • Evaluation of health-related quality of life, fatigue and depression in neuromyelitis optica
    • Chanson, J. B. et al. Evaluation of health-related quality of life, fatigue and depression in neuromyelitis optica. Eur. J. Neurol. 18, 836-841 (2011).
    • (2011) Eur. J. Neurol. , vol.18 , pp. 836-841
    • Chanson, J.B.1
  • 162
    • 84920582445 scopus 로고    scopus 로고
    • Current symptomatology in multiple sclerosis and neuromyelitis optica
    • Muto, M. et al. Current symptomatology in multiple sclerosis and neuromyelitis optica. Eur. J. Neurol. 22, 299-304 (2015).
    • (2015) Eur. J. Neurol. , vol.22 , pp. 299-304
    • Muto, M.1
  • 163
    • 85014646526 scopus 로고    scopus 로고
    • Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder
    • Chavarro, V. S. et al. Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder. Neurol. Neuroimmunol. Neuroinflamm. 3, e286 (2016).
    • (2016) Neurol. Neuroimmunol. Neuroinflamm. , vol.3 , pp. e286
    • Chavarro, V.S.1
  • 164
    • 84959216202 scopus 로고    scopus 로고
    • Factors that impact health-related quality of life in neuromyelitis optica spectrum disorder: Anxiety, disability, fatigue and depression
    • Shi, Z. et al. Factors that impact health-related quality of life in neuromyelitis optica spectrum disorder: Anxiety, disability, fatigue and depression. J. Neuroimmunol. 293, 54-58 (2016).
    • (2016) J. Neuroimmunol. , vol.293 , pp. 54-58
    • Shi, Z.1
  • 165
    • 84929580984 scopus 로고    scopus 로고
    • Depressive state and chronic fatigue in multiple sclerosis and neuromyelitis optica
    • Akaishi, T., Nakashima, I., Misu, T., Fujihara, K. & Aoki, M. Depressive state and chronic fatigue in multiple sclerosis and neuromyelitis optica. J. Neuroimmunol. 283, 70-73 (2015).
    • (2015) J. Neuroimmunol. , vol.283 , pp. 70-73
    • Akaishi, T.1    Nakashima, I.2    Misu, T.3    Fujihara, K.4    Aoki, M.5
  • 166
    • 84977831621 scopus 로고    scopus 로고
    • Sleep abnormality in neuromyelitis optica spectrum disorder
    • Song, Y. et al. Sleep abnormality in neuromyelitis optica spectrum disorder. Neurol. Neuroimmunol. Neuroinflamm. 2, e94 (2015).
    • (2015) Neurol. Neuroimmunol. Neuroinflamm. , vol.2 , pp. e94
    • Song, Y.1
  • 167
    • 0036152780 scopus 로고    scopus 로고
    • Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: A two centre phase 2 study
    • Rammohan, K. W. et al. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: A two centre phase 2 study. J. Neurol. Neurosurg. Psychiatry 72, 179-183 (2002).
    • (2002) J. Neurol. Neurosurg. Psychiatry , vol.72 , pp. 179-183
    • Rammohan, K.W.1
  • 168
    • 20144389425 scopus 로고    scopus 로고
    • Modafinil for fatigue in MS: A randomized placebo-controlled double-blind study
    • Stankoff, B. et al. Modafinil for fatigue in MS: A randomized placebo-controlled double-blind study. Neurology 64, 1139-1143 (2005).
    • (2005) Neurology , vol.64 , pp. 1139-1143
    • Stankoff, B.1
  • 169
    • 80052010239 scopus 로고    scopus 로고
    • HAGIL (Hamburg Vigil Study): A randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis
    • Möller, F. et al. HAGIL (Hamburg Vigil Study): A randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis. Mult. Scler. 17, 1002-1009 (2011).
    • (2011) Mult. Scler. , vol.17 , pp. 1002-1009
    • Möller, F.1
  • 170
    • 67349149115 scopus 로고    scopus 로고
    • Modafinil effects in multiple sclerosis patients with fatigue
    • Lange, R., Volkmer, M., Heesen, C. & Liepert, J. Modafinil effects in multiple sclerosis patients with fatigue. J. Neurol. 256, 645-650 (2009).
    • (2009) J. Neurol. , vol.256 , pp. 645-650
    • Lange, R.1    Volkmer, M.2    Heesen, C.3    Liepert, J.4
  • 171
    • 0036038978 scopus 로고    scopus 로고
    • Modafinil in treatment of fatigue in multiple sclerosis
    • Zifko, U. A., Rupp, M., Schwarz, S., Zipko, H. T. & Maida, E. M. Modafinil in treatment of fatigue in multiple sclerosis. J. Neurol. 249, 983-987 (2002).
    • (2002) J. Neurol. , vol.249 , pp. 983-987
    • Zifko, U.A.1    Rupp, M.2    Schwarz, S.3    Zipko, H.T.4    Maida, E.M.5
  • 172
    • 33751402462 scopus 로고    scopus 로고
    • P300 and treatment effect of modafinil on fatigue in multiple sclerosis
    • Nagels, G. et al. P300 and treatment effect of modafinil on fatigue in multiple sclerosis. J. Clin. Neurosci. 14, 33-40 (2007).
    • (2007) J. Clin Neurosci. , vol.14 , pp. 33-40
    • Nagels, G.1
  • 173
    • 84958916709 scopus 로고    scopus 로고
    • Cognitive effects of modafinil in patients with multiple sclerosis: A clinical trial
    • Ford-Johnson, L. et al. Cognitive effects of modafinil in patients with multiple sclerosis: A clinical trial. Rehabil. Psychol. 61, 82-91 (2016).
    • (2016) Rehabil. Psychol. , vol.61 , pp. 82-91
    • Ford-Johnson, L.1
  • 174
    • 0842305087 scopus 로고    scopus 로고
    • Comparison of the effects of acetyl l carnitine and amantadine for the treatment of fatigue in multiple sclerosis: Results of a pilot, randomised, double-blind, crossover trial
    • Tomassini, V. et al. Comparison of the effects of acetyl l carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial. J. Neurol. Sci. 218, 103-108 (2004).
    • (2004) J. Neurol. Sci. , vol.218 , pp. 103-108
    • Tomassini, V.1
  • 175
    • 16844368558 scopus 로고    scopus 로고
    • A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis
    • Wingerchuk, D. M. et al. A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis. Neurology 64, 1267-1269 (2005).
    • (2005) Neurology , vol.64 , pp. 1267-1269
    • Wingerchuk, D.M.1
  • 176
    • 84941287013 scopus 로고    scopus 로고
    • Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients
    • Pavsic, K., Pelicon, K., Ledinek, A. H. & Sega, S. Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients. Clin. Neurol. Neurosurg. 139, 35-40 (2015).
    • (2015) Clin. Neurol. Neurosurg. , vol.139 , pp. 35-40
    • Pavsic, K.1    Pelicon, K.2    Ledinek, A.H.3    Sega, S.4
  • 177
    • 84939256479 scopus 로고    scopus 로고
    • Sustained-released fampridine in multiple sclerosis: Effects on gait parameters, arm function, fatigue, and quality of life
    • Allart, E. et al. Sustained-released fampridine in multiple sclerosis: effects on gait parameters, arm function, fatigue, and quality of life. J. Neurol. 262, 1936-1945 (2015).
    • (2015) J. Neurol. , vol.262 , pp. 1936-1945
    • Allart, E.1
  • 178
    • 74249114595 scopus 로고    scopus 로고
    • Using modafinil to treat fatigue in Parkinson disease: A double-blind, placebo-controlled pilot study
    • Lou, J. S. et al. Using modafinil to treat fatigue in Parkinson disease: A double-blind, placebo-controlled pilot study. Clin. Neuropharmacol. 32, 305-310 (2009).
    • (2009) Clin. Neuropharmacol. , vol.32 , pp. 305-310
    • Lou, J.S.1
  • 179
    • 77951208074 scopus 로고    scopus 로고
    • Modafinil for Parkinson's disease fatigue
    • Tyne, H. L., Taylor, J., Baker, G. A. & Steiger, M. J. Modafinil for Parkinson's disease fatigue. J. Neurol. 257, 452-456 (2010).
    • (2010) J. Neurol. , vol.257 , pp. 452-456
    • Tyne, H.L.1    Taylor, J.2    Baker, G.A.3    Steiger, M.J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.